Marta Seca

机构：University of Milano-Bicocca · ORCID：0000-0003-1944-0842

发表论文 35 篇 · 总被引 112 次 · h-index 6

代表论文

• Relugolix for the treatment of uterine fibroids (2019 · Drugs of today · 被引 35)
• Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study (2025 · ESMO Open · 被引 18)
• The potential role of elagolix for treating uterine bleeding associated to uterine myomas (2020 · Expert Opinion on Pharmacotherapy · 被引 13)
• Breast cancer and ATM mutations: treatment implications (2024 · Hereditary Cancer in Clinical Practice · 被引 9)
• Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2 (2025 · JNCI Journal of the National Cancer Institute · 被引 7)
• About uterine enhanced myometrial vascularity: Doppler ultrasound could reduce misdiagnosed life-threatening vaginal bleeding after pregnancy and guide the management (2022 · Journal of Ultrasound · 被引 7)